BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25646754)

  • 1. Why endocrine disrupting chemicals (EDCs) challenge traditional risk assessment and how to respond.
    Futran Fuhrman V; Tal A; Arnon S
    J Hazard Mater; 2015 Apr; 286():589-611. PubMed ID: 25646754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
    Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
    Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penile density and globally used chemicals in Canadian and Greenland polar bears.
    Sonne C; Dyck M; Rigét FF; Beck Jensen JE; Hyldstrup L; Letcher RJ; Gustavson K; Gilbert MT; Dietz R
    Environ Res; 2015 Feb; 137():287-91. PubMed ID: 25601730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of research on endocrine disruption for the environmental risk assessment, regulation and monitoring of chemicals in the European Union.
    Matthiessen P; Johnson I
    Environ Pollut; 2007 Mar; 146(1):9-18. PubMed ID: 16996184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol Lett; 2020 Oct; 331():259-264. PubMed ID: 32360654
    [No Abstract]   [Full Text] [Related]  

  • 8. Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals.
    Beronius A; Vandenberg LN
    Rev Endocr Metab Disord; 2015 Dec; 16(4):273-87. PubMed ID: 26847432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging the gap between academic research and regulatory health risk assessment of Endocrine Disrupting Chemicals.
    Beronius A; Hanberg A; Zilliacus J; Rudén C
    Curr Opin Pharmacol; 2014 Dec; 19():99-104. PubMed ID: 25238457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology.
    Vandenberg LN; Colborn T; Hayes TB; Heindel JJ; Jacobs DR; Lee DH; Myers JP; Shioda T; Soto AM; vom Saal FS; Welshons WV; Zoeller RT
    Reprod Toxicol; 2013 Jul; 38():1-15. PubMed ID: 23411111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
    Lee DH; Jacobs DR
    J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental epigenomics: Current approaches to assess epigenetic effects of endocrine disrupting compounds (EDC's) on human health.
    Tapia-Orozco N; Santiago-Toledo G; Barrón V; Espinosa-García AM; García-García JA; García-Arrazola R
    Environ Toxicol Pharmacol; 2017 Apr; 51():94-99. PubMed ID: 28215500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
    Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
    Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.
    Rachoń D
    Rev Endocr Metab Disord; 2015 Dec; 16(4):359-64. PubMed ID: 26831296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A path forward in the debate over health impacts of endocrine disrupting chemicals.
    Zoeller RT; Bergman Å; Becher G; Bjerregaard P; Bornman R; Brandt I; Iguchi T; Jobling S; Kidd KA; Kortenkamp A; Skakkebaek NE; Toppari J; Vandenberg LN
    Environ Health; 2014 Dec; 13():118. PubMed ID: 25533907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health risk assessment of endocrine disrupting chemicals].
    Tohyama C; Ohsako S; Ishimura R
    Nihon Rinsho; 2000 Dec; 58(12):2393-400. PubMed ID: 11187727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental endocrine disruptors: Effects on the human male reproductive system.
    Sweeney MF; Hasan N; Soto AM; Sonnenschein C
    Rev Endocr Metab Disord; 2015 Dec; 16(4):341-57. PubMed ID: 26847433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.